학술논문
Short‐term efficacy and safety of antithymocyte globulin treatment in elderly patients with acquired aplastic anaemia.
Document Type
Article
Author
Source
Subject
*APLASTIC anemia treatment
*DRUG efficacy
*MEDICATION safety
*OLDER patients
*ANEMIA
*
*
*
*
Language
ISSN
0007-1048
Abstract
The article presents a study which examined the short-term efficacy and safety of antithymocyte globulin treatment (ATG) in elderly patients with acquired aplastic anaemia. Also cited are the combined horse-derived ATG and ciclosporin (CSA) as standard first-line immunosuppressive therapy (IST) for the disease, and the results showing that age should not be an absolute contraindication for using ATG and CSA to treat older patients with acquired aplastic anaemia.